The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...
Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...
The FDA has accepted for review Chiesi’s New Drug Application (NDA) for their investigational maintenance treatment for ...
Amneal has received tentative approval from the Food and Drug Administration for an inhalation aerosol to treat asthma. The biopharmaceutical company said the product, called beclomethasone ...
Starting this April, the biggest health insurer in Texas plans to restrict treatment options for patients suffering from severe asthma. Blue Cross Blue Shield — which covers more than 10 million ...
Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) diseases that cause breathing difficulty and coughing. Asthma affects about 28 million people in the United ...
An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback